Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $78.70 USD
Change Today -0.30 / -0.38%
Volume 1.3M
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Rajiv Kanishka Liyanaarchchie De Silva

Chief Executive Officer, President and Director,Endo International plc
AgeTotal Calculated CompensationThis person is connected to 13 board members in 4 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Rajiv Kanishka Liyanaarchchie De Silva has been the Chief Executive Officer and President of Endo International plc since March 18, 2013. Mr. De Silva serves as the Chief Executive Officer and President of Endo Pharmaceuticals Inc. He served as the President of Valeant Pharmaceuticals International, Inc. from October 2010 to January 15, 2013 and served as its Chief Operating Officer until January 15,2013. He was responsible for all specialty pharmaceutical operations, ...

Read Full Background

Corporate Headquarters*

Minerva House
Dublin, Co. Dublin 4


Phone: 353 1 268 2000
Fax: --

Board Members Memberships*

Chief Executive Officer, President and Director
Chief Executive Officer, President and Director
Chief Executive Officer, President and Director


Stanford University
Princeton University
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,079,167

Stock Options*

Restricted Stock Awards$3,623,783
All Other Compensation$12,726,292
Exercisable Options90,598
Exercisable Options Value$3,777,937
Unexercisable Options148,585
Unexercisable Options Value$2,746,309
Total Value of Options$6,524,245
Total Number of Options239,183

Total Compensation*

Total Annual Cash Compensation$16,625,067
Total Short Term Compensation$1,079,167
Other Long Term Compensation$16,350,075
Total Calculated Compensation$22,071,596
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENDP:US $78.70 USD -0.30


Jean-Paul Clozel M.D.Founder, Chief Executive Officer and Director
Actelion Ltd.
Timothy M. Ring Chairman, Chief Executive Officer and Chairman of Executive Committee
CR Bard Inc.
Michael A. Mussallem Chairman and Chief Executive Officer
Edwards Lifesciences Corp.
Jean-Christophe Tellier Chief Executive Officer and Executive Director
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENDO INTERNATIONAL PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at